This site is intended for healthcare professionals only
LoginRegister
European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescentsNo nationwide shortage of HIV drug Dolutegravir: Mansukh Mandaviya
Safipur CHC Burns Medicines, Investigation LaunchedIndia finds multiple deficiencies among drugmakers following inspections across industry
Mansukh Mandaviya calls for mandatory adoption of Good Manufacturing Practices by all pharma companiesMansukh Mandaviya calls for mandatory adoption of Good Manufacturing Practices by all pharma...
Budget Quotes - Mankind Pharma, Bharat Serum and Vaccines & Park Medi WorldMankind Pharma reports 66 percent jump in Q1 profit
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkPatent infringement: Roche sues Novartis unit over generic lung disease drug
Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technologyPfizer sued by GSK for patent infringement over RSV vaccine
Zydus Lifesciences bags USFDA nod for Indomethacin Suppository for rheumatoid arthritisZydus Lifesciences bags USFDA nod for Indomethacin Suppository for rheumatoid arthritis
WHO includes Cadila Pharma Polycap combination in Essential Medicine ListWHO includes Cadila Pharma Polycap combination in Essential Medicine List
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyBid to buy Glenmark Life for Rs 7000 crore: Nirma leads acquisition race with ChrysCap, Sekhmet
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer considers cost cuts as demand for COVID products falls
Glenmark gets USFDA nod for generic version of AstraZeneca diabetes drug OnglyzaGlenmark gets USFDA nod for generic version of AstraZeneca diabetes drug Onglyza
Daiichi Sankyo Daichirona for Intramuscular Injection approved for manufacturing, marketing as booster vaccination in JapanDaiichi Sankyo Daichirona for Intramuscular Injection approved for manufacturing, marketing as...
X